From: Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19
Clinical features | Critical COVID-19 | Severe COVID-19 | Mild COVID-19 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Asthma (n = 16) | Asthma (n = 3) | P | Non-Asthma (n = 26) | Asthma (n = 10) | P | Non-Asthma (n = 22) | Asthma (n = 3) | P | ||||
Age | 55 ± 12 | 70 ± 11 | 0.077 | 67 ± 16 | 56 ± 16 | 0.066 | 70 ± 20 | 37 ± 17 | 0.014 | |||
BMI (kg/cm2) | 29.57 ± 7.10 | 27.52 ± 6.74 | 0.741 | 31.45 ± 6.51 | 28.92 ± 4.63 | 0.475 | 24.92 ± 3.50 | 26.94 ± 1.74 | 0.465 | |||
Gender (M/F) | 11/5 | 3/0 | 0.530 | 13/13 | 7/3 | 0.456 | 10/12 | 1/2 | 1.000 | |||
Ethnicity | Â | Â | 0.308 | Â | Â | 0.622 | Â | Â | 0.071 | |||
 Caucasians | 6 (40.0%) | 3 (100.0%) |  | 19 (76.0%) | 9 (90.0%) |  | 15 (78.9%) | 2 (66.7%) |  | |||
 Asian | 3 (20.0%) | 0 (0%) |  | 1 (4.0%) | 1 (10.0%) |  | 3 (15.8%) | 0 (0%) |  | |||
 African | 0 (0%) | 0 (0%) |  | 3 (12.0%) | 0 (0%) |  | 0 (0%) | 1 (33.3%) |  | |||
 Mediterranean | 0 (0%) | 0 (0%) |  | 0 (0%) | 0 (0%) |  | 0 (0%) | 0 (0%) |  | |||
 Mixed | 1 (6.7%) | 0 (0%) |  | 1 (4.0%) | 0 (0%) |  | 0 (0%) | 0 (0%) |  | |||
 Others | 5 (33.3%) | 0 (0%) |  | 1 (4.0%) | 0 (0%) |  | 1 (5.3%) | 0 (0%) |  | |||
Smoking | Â | Â | 1.000 | Â | Â | 0.304 | Â | Â | 0.242 | |||
 Non-smokers | 10 (66.7%) | 2 (66.7%) |  | 17 (68.0%) | 4 (44.4%) |  | 9 (52.9%) | 3 (100.0%) |  | |||
 Ex-smokers | 5 (33.3%) | 1 (33.3%) |  | 7 (28.0%) | 5 (55.6%) |  | 8 (47.1%) | 0 (0%) |  | |||
 Active smokers | 0 (0%) | 0 (0%) |  | 1 (4.0%) | 0 (0%) |  | 0 (0%) | 0 (0%) |  | |||
Days of symptoms to sampling | 12.81 ± 5.41 | 10.33 ± 3.22 | 0.459 | 9.31 ± 5.13 | 11.60 ± 5.36 | 0.243 | 6.86 ± 3.58 | 13.33 ± 11.15 | 0.037 | |||
Comorbidities | ||||||||||||
 CCI | 1.44 ± 4.07 | 6.67 ± 2.52 | 0.049 | 8.77 ± 10.11 | 7.60 ± 9.36 | 0.753 | 7.32 ± 9.44 | 4.00 ± 0 | 0.556 | |||
 Hypertension | 6 (37.5%) | 2 (66.7%) | 0.546 | 14 (53.8%) | 3 (30.0%) | 0.274 | 8 (36.4%) | 0 (0%) | 0.527 | |||
 CRD | 1 (6.3%) | 0 (0.0%) | 1.000 | 6 (23.1%) | 1 (10.0%) | 0.645 | – | – | – | |||
 CCD | 1 (6.3%) | 1 (33.3%) | 0.298 | 3 (11.5%) | 1 (10.0%) | 1.000 | 5 (22.7%) | 0 (0%) | 1.000 | |||
 DM | 3 (18.8%) | 1 (33.3%) | 0.530 | 15 (57.7%) | 3 (30.0%) | 0.137 | 6 (27.3%) | 0 (0%) | 0.554 | |||
 Haemcancer | – | – | – | – | – | – | – | – | – | |||
 Other cancer | – | – | – | – | – | – | 1 (4.5%) | 0 (0%) | 1.000 | |||
 Liver diseases | 1 (6.3%) | 0 (0%) | 1.000 | 0 (0%) | 1 (10.0%) | 0.278 | – | – | – | |||
 Neurological diseases | – | – | – | 0 (0%) | 1 (10.0%) | 0.278 | – | – | – | |||
 Kidney diseases | – | – | – | – | – | – | 1 (4.5%) | 0 (0%) | 1.000 | |||
 Transplantation | – | – | – | – | – | – | – | – | – | |||
 Rheumatological diseases | – | – | – | – | – | – | 1 (4.5%) | 0 (0%) | 1.000 | |||
 Immunosuppression | – | – | – | – | – | – | 0 (0%) | 1 (33.3%) | 0.120 | |||
 Stroke/dementia | – | – | – | – | – | – | 2 (9.1%) | 0 (0%) | 1.000 | |||
SaO2/FiO2 | 1.72 ± 0.49 | 1.83 ± 0.57 | 0.783 | 2.65 ± 1.10 | 2.75 ± 1.30 | 0.845 | 4.57 ± 0.10 | 4.52 ± 0.13 | 0.569 | |||
WBC (×109/L) | 9.45 ± 3.54 | 7.74 ± 2.52 | 0.441 | 7.85 ± 3.59 | 7.54 ± 2.68 | 0.814 | 7.58 ± 2.81 | 5.48 ± 4.32 | 0.273 | |||
Neutrophils (×109/L) | 8.06 ± 3.44 | 6.89 ± 2.41 | 0.585 | 6.23 ± 3.48 | 5.76 ± 2.89 | 0.723 | 5.66 ± 2.50 | 3.67 ± 3.52 | 0.235 | |||
Eosinophils (×109/L) | 0.08 ± 0.08 | 0.08 ± 0.09 | 0.909 | 0.03 ± 0.04 | 0.09 ± 0.10 | 0.059 | 0.06 ± 0.06 | 0.07 ± 0.06 | 0.711 | |||
Lymphocytes (×109/L) | 0.93 ± 0.37 | 0.49 ± 0.15 | 0.062 | 1.01 ± 0.43 | 1.16 ± 0.40 | 0.387 | 1.35 ± 0.57 | 1.12 ± 0.22 | 0.492 | |||
Monocytes (×109/L) | 0.39 ± 0.21 | 0.26 ± 0.21 | 0.325 | 0.55 ± 0.32 | 0.52 ± 0.31 | 0.761 | 0.50 ± 0.26 | 0.63 ± 0.66 | 0.545 | |||
Haemoglobin (g/L) | 114.31 ± 22.53 | 111.33 ± 15.89 | 0.831 | 126.09 ± 15.96 | 126.88 ± 15.01 | 0.905 | 126.85 ± 16.54 | 127.67 ± 6.03 | 0.935 | |||
Platelets (×109/L) | 265.31 ± 111.65 | 234.33 ± 39.51 | 0.647 | 292.16 ± 121.19 | 356.50 ± 90.69 | 0.163 | 272.68 ± 98.73 | 259.67 ± 34.15 | 0.826 | |||
Lactate (mmol/L) (highest) | 1.294 ± 0.6567 | 1.100 ± 0.1000 | 0.625 | 1.529 ± 0.4327 | 0.962 ± 0.2560 | 0.002 | 1.520 ± 0.3824 | 0.900 ± 0.1414 | 0.053 | |||
Bicarbonate (mmol/L) (highest) | 24.71 ± 4.04 | 25.77 ± 2.66 | 0.673 | 24.37 ± 3.30 | 25.64 ± 1.56 | 0.316 | 24.88 ± 2.73 | 23.95 ± 1.48 | 0.658 | |||
CRP (highest) | 233.90 ± 156.36 | 207.93 ± 60.54 | 0.784 | 163.73 ± 85.65 | 106.82 ± 49.61 | 0.073 | 74.87 ± 61.52 | 56.43 ± 30.81 | 0.622 | |||
ALP (highest) | 97.81 ± 45.51 | 69.33 ± 13.58 | 0.307 | 103.71 ± 66.26 | 106.50 ± 93.33 | 0.929 | 118.06 ± 92.09 | 64.00 ± 8.19 | 0.335 | |||
ALT (highest) | 66.25 ± 42.61 | 55.33 ± 17.10 | 0.673 | 50.71 ± 42.91 | 74.89 ± 86.65 | 0.311 | 55.56 ± 79.51 | 32.00 ± 22.11 | 0.624 | |||
d-Dimer (timepoint) | 13,585.44 ± 22,511.816 | 2240.00 ± 0 | 0.645 | 2574.86 ± 6268.18 | 3491.00 ± 5068.18 | 0.730 | 9842.67 ± 26,319.981 | 2738.00 ± 2586.597 | 0.723 | |||
LDH (timepoint) | 600.00 ± 79.076 | – | – | 526.00 ± 281.27 | 315.50 ± 102.19 | 0.178 | 433.67 ± 104.45 | – | – | |||
CK (timepoint) | 299.00 ± 450.172 | – | – | 332.64 ± 849.60 | 116.20 ± 89.85 | 0.586 | 211.90 ± 180.90 | – | – | |||
OS score | 0.76 ± 1.19 | 1.96 ± 0.96 | 0.122 | 1.95 ± 1.47 | 1.04 ± 1.98 | 0.138 | 1.81 ± 1.77 | − 1.13 ± 1.11 | 0.011 | |||
Vasopressors | 14 (87.5%) | 3 (100.0%) | 1.000 | 2 (7.7%) | 2 (20.0%) | 0.305 | – | – | – | |||
Days on vasopressors | 10.13 ± 8.84 | 8.00 ± 5.57 | 0.697 | 1.25 ± 3.15 | 2.50 ± 4.36 | 0.579 | – | – | – | |||
RRT | 6 (37.5%) | 0 (0%) | 0.517 | 1 (3.8%) | 1 (10.0%) | 0.484 | – | – | – | |||
Days on RRT | 3.019 ± 5.73 | – | – | 0.88 ± 2.48 | 0.50 ± 1.00 | 0.781 | – | – | – | |||
Days on ventilation (days) | 24.44 ± 11.88 | 11.67 ± 4.16 | 0.089 | 9.13 ± 12.08 | 7.00 ± 8.45 | 0.761 | – | – | – | |||
Hospital LOS (days) | 40.44 ± 20.36 | 17.67 ± 0.58 | 0.076 | 14.42 ± 14.34 | 10.70 ± 6.78 | 0.439 | 7.14 ± 6.72 | 4.67 ± 3.79 | 0.544 | |||
Mortality | 2 (12.5%) | 1 (33.3%) | 0.422 | 7 (26.9%) | 1 (10.0%) | 0.397 | 2 (9.1%) | 0 (0%) | 1.000 |